Skip to main content

Table 2 The 15 miRNAs with lowest p -values for differential expression between TZ and PZ in normal prostate tissue and their previously identified differentially expressed target genes

From: Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate

miRNA

+/−

Predicted (validated) target

Noel et al. [20]

Van der Heul-Nieuwenhuijsen et al. [21]

genes

miR-433

+

880 ( 2 )

*

NAT1, SRPX, KLK3, EDN3, KIAA1324

miR-494

+

707 ( 1 )

DHX9, SYTL2

PCOLCE, LUM, SRPX, RAB27A, MED28, PCP4, CCL2

miR-22*

+

696 ( 0 )

*

BAMBI, PFKFB3, RAB10, NEXN, ATF3, FOLH1, CEBPD, SNX25, MED28, LRRC28

miR-15a*

-

664 ( 0 )

*

PFKFB3, EGR2, EGR1, BIK, KLK3,

PBEF1, TRPM4, DDX5

miR-15b*

-

669 ( 0 )

*

NEXN, SRPX, EGR1, HAT1, PBEF1,

UAP1

miR-379

+

799 ( 1 )

S100A4

C6orf115, GMNN, RBP1, CALD1, ASPA, DBI, ATP2C1, SERPINI1, SRPX, DUSP1, ECM1, RABGGTB, GRP58, TM4SF1, CCL2

miR-216b

-

862 ( 0 )

HSD11B1

EAF2, C6orf115, IFNGR1, TFPI2,

HAT1, PENK, PBEF1, LPHN2, SFRS9

miR-181c

-

990 ( 5 )

HSD11B1

GATA6, SFRS5, KCNMA1, FKBP1A, ZFYVE26, KLF6, PRKAG2, THBS4, LPHN2, SPOCK3, EIF4A2, TACSTD2, MYBPC1, TGBR3, RAB3IP, TUBB

miR-543

+

875 ( 0 )

*

KCNMA1, C6orf115, DACH1, FKBP1A. PRKAG2, SERPINI1, RABGGTB, THBS4, PTGS2, TM4SF1, EIF4A2,SFRS9, KIAA1324, RAB3IP, CCL2

miR-27b*

+

722 ( 0 )

HSD11B1

ASPA, MLPH, FBXO2, BRI3, PRRX2, PENK, UAP1, SGCE, TRIM36, EIF4A2, TBCA

miR-154

+

738 ( 0 )

EFEMP1

EAF2, TNFSF10, GMNN, CSRP2,

GCAT, SRPX, FEZ1, SGCE, DDX5

miR-424*

+

535 ( 1 )

DHX9, HOXD13

HEPH, C6orf115, FKBP1A, PRKAG2, HPN, ECM1, THBS4, COL16A1, CCL2

miR-495

+

896 ( 0 )

*

SFRS5, TACSTD1, C6orf115, JUNB, SERPINI1, MCM2, NANS, DUSP1, CITED2, LIMS2, NIPA2, NDN, PBEF1, TFF1, UAP1, RPRM, CYP1B1, RAB3IP, CCL2

miR-337-3p

+

888 ( 0 )

SPON1

NRG2, TRIT1, ATF3, SPON1, CSRP2,

C15orf5, COL16A1, NDN, LHFP

miR-127-3p

+

741 ( 0 )

C6orf32, NELL2

XBP1, KCNMA1, FKBP1A, GCAT, GPR30, KCNJ8, TUBGCP2, TFF1, PTGDS, GADD45G

  1. +/− Up/down-regulated in the transition zone compared to the peripheral zone.
  2. * No target gene (validated or predicted) overlap.
  3. Genes marked in bold are validated target genes.
  4. Italicized genes have been found to be differentially expressed between PZ and TZ in both reference papers [20, 21].